Survival analyses from the ZEBRA study. Goserelin (Zoladex) versus CMF in premenopausal women with node positive breast cancer. - Kaufmann,M.; Jonat,W.; Blamey,R.; Cuzick,J.; Namer,M.; Fogelman,I.; de Haes,J.C.; Schumacher,M.; Sauerbrei,W. (Eur J Cancer, 2003)